Manufacturing facility
BioReliance Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Not on file
- Registered address
- —
- Operations here
- —
- FDA identifiers
- DUNS 147227730
Drugs this plant is listed as making
3 distinct drugs across 5 products name this site in their FDA label.
- cemiplimab-rwlcRegeneron Pharmaceuticals, Inc.
- talquetamabJanssen Biotech, Inc.
- TocilizumabBiogen MA Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.